Structure-Activity Relationships

A structure-activity relationship (SAR) describes how the chemical structure of a compound determines its biological activity. In natural-product research, SAR analysis explains why a particular scaffold or substituent makes a molecule active, guides the optimisation of natural leads, and underlies the quantitative models (QSAR) used in modern drug design.

Definition

A structure-activity relationship is the relationship between the molecular structure of a chemical compound and its biological activity, such that systematic changes in structure produce predictable changes in potency, selectivity, or other pharmacological properties.

Scope

The entry covers the concept that activity is a function of molecular structure, the qualitative reasoning that relates functional groups and stereochemistry to potency, the quantitative (QSAR) tradition that began with Hansch analysis, and the application of SAR to optimising bioactive natural products. It is a methodological reference, not clinical guidance.

Core questions

• Which structural features of a natural product are responsible for its activity?
• How can a lead compound be modified to improve potency or selectivity?
• Can biological activity be quantitatively predicted from molecular descriptors?

Key concepts

• Pharmacophore
• Functional group contribution
• Stereochemistry and chirality
• Lipophilicity (logP)
• Molecular descriptors
• Rule-of-five drug-likeness
• Lead optimisation

Key theories

Hansch analysis (classical QSAR)

Hansch and Fujita proposed that biological activity can be correlated with physicochemical parameters — hydrophobicity, electronic, and steric terms — through linear free-energy relationships, founding the quantitative structure-activity relationship approach.

Mechanisms

Biological activity arises from the fit and interaction between a molecule and its target, so structural features that govern binding — shape, electronic distribution, hydrogen-bond donors and acceptors, hydrophobicity, and stereochemistry — determine activity. Qualitative SAR identifies which substituents enhance or abolish activity, while quantitative SAR (QSAR), following Hansch and Fujita, correlates activity with calculated physicochemical descriptors to build predictive models. Empirical 'rules' such as Lipinski's rule of five and the Veber criteria summarise how molecular properties relate to oral absorption, providing structure-based filters during optimisation.

Clinical relevance

SAR reasoning explains how natural leads are turned into optimised drug candidates and why related compounds differ in activity, which is part of medicinal-chemistry and pharmacognosy education. It describes how molecular structure maps to activity and is a reference framework, not a basis for individual treatment decisions.

Evidence & guidelines

The evidence base is primarily chemical and computational: bioassay potency data analysed against structural variation, and predictive QSAR models validated on test sets. Drug-likeness heuristics such as the rule of five and Veber rules are widely used filters rather than formal clinical guidelines.

History

Qualitative structure-activity ideas date to nineteenth-century pharmacology, but the quantitative era began in 1964 when Hansch and Fujita introduced linear free-energy correlations between activity and physicochemical parameters. Later, property-based heuristics — Lipinski's rule of five (1997) and the Veber rules (2002) — distilled large datasets into practical guidelines, and SAR/QSAR became central to optimising both synthetic and natural-product leads.

Debates

How far do drug-likeness rules apply to natural products?

Many bioactive natural products violate Lipinski-type rules yet remain orally active, so the applicability of property-based filters to natural-product chemical space is contested and treated as guidance rather than strict cutoffs.

Key figures

• Corwin Hansch
• Toshio Fujita
• Christopher A. Lipinski

Seminal works

• hansch-fujita-1964
• lipinski-1997
• veber-2002

Frequently asked questions

What is the difference between SAR and QSAR?

SAR is the general, often qualitative, observation that structure determines activity; QSAR (quantitative SAR) builds mathematical models that correlate activity with calculated molecular descriptors, allowing activity to be predicted for new compounds.

Why do some active natural products break the 'rule of five'?

Drug-likeness rules were derived mainly from synthetic oral drugs; natural products can be absorbed through transporters or have structural features that allow activity despite higher molecular weight or more hydrogen-bonding groups, so the rules are guidance rather than absolute limits.